Scientists regrow nerves in paralysed rats' spinal cords using human cells
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Skin cells from an 86-year-old man have been turned into nerve cells that were able to grow within the damaged spinal cords of paralysed rats – raising the prospect that the technique might one day be used to treat paraplegic patients with spinal injuries.
Scientists found that skin cells taken from the elderly man can be reprogrammed into adult nerve cells or neurons using a technique called induced pluripotent stem (iPS) cells. The human neurons made “tens of thousands” of nerve connections that grew almost the entire length of the rats’ damaged spinal cords.
When the human neurons were transplanted into the animals, the nerve connections or “axons” grew straight through the damaged region of the spinal cord and even entered the brain, the scientists said. However, there was no corresponding functional improvement in the paralysis of the rats, according to a study in the journal Neuron.
“These findings indicate that intrinsic neuronal mechanisms readily overcome the barriers created by a spinal cord injury to extend many axons over very long distances, and that these capabilities persist even in neurons reprogrammed from very aged human cells,” said Mark Tuszynski, professor of neurosciences at the University of California, San Diego.
Many research projects are aimed at finding a way of using stem cells to repair spinal cord injuries, especially in the critical few weeks following an accident when it may be the best moment to trigger the regeneration of damaged nerves.
“95 per cent of human clinical trials fail. We are trying to do as much as we possibly can to identify the best way of translating neural stem cell therapies for spinal cord injury to patients,” Professor Tuszynski said.
“It’s easy to forge ahead with incomplete information, but the risk of doing so is greater likelihood of another failed clinical trial. We want to determine as best we can the optimal cell type and best method for human translation so that we can move ahead rationally and, with some luck, successfully,” he said.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments